Bio-Rad Laboratories (NYSE: BIO) — Perfil da empresa, notícias e dados financeiros
Bio-Rad Laboratories is a global developer, manufacturer, and marketer of life science research products and clinical diagnostics.
Bio-Rad Laboratories
Bio-Rad Laboratories is a global developer, manufacturer, and marketer of life science research products and clinical diagnostics. The company operates through two main reporting segments: Life Science and Clinical Diagnostics. Its Life Science segment produces instruments, software, reagents, and consumables used in biological research, cell analysis, gene expression, and protein purification. Its Clinical Diagnostics segment designs and manufactures automated systems, test kits, and quality control materials for medical laboratories, blood banks, and clinical facilities worldwide. Bio-Rad serves university research institutions, pharmaceutical and biotechnology companies, hospitals, public health organizations, and commercial laboratories across global markets.
Resumo
Operações
Produtos e/ou serviços de Bio-Rad Laboratories
- Clinical Diagnostics Quality Control Solutions: Automated quality control systems, multi-analyte controls, and data management software designed for clinical laboratories and hospital networks to evaluate diagnostic test accuracy, monitor instrument precision, and maintain regulatory compliance.
- Droplet Digital PCR and PCR Systems: Digital thermal cyclers, real-time quantitative PCR instruments, and specialized reagents that perform high-precision nucleic acid amplification, biomarker detection, rare sequence quantification, and gene expression analysis for research and clinical testing.
- Immunohematology and Blood Typing Systems: Automated screening instruments, microplate readers, and reagent panels used by blood centers, donor screening facilities, and hospital transfusion services for blood group typing, antibody identification, and disease screening.
- Chromatography Resins and Downstream Bioprocessing Media: Process-scale chromatography columns, ion-exchange media, and mixed-mode resins optimized for biopharmaceutical separation, protein purification, monoclonal antibody manufacturing, and downstream scale-up from research to commercial production.
- Protein Electrophoresis and Western Blotting Products: Specialized gel electrophoresis equipment, precast gels, imaging systems, and transfer membrane reagents used in academic and industrial life science laboratories for protein separation, detection, and characterization.
- Food Safety and Quality Testing Assays: Pathogen detection kits, indicator organism assays, and automated testing platforms engineered for agricultural suppliers, food processing facilities, and beverage manufacturers to screen raw materials and finished products.
equipe executiva do Bio-Rad Laboratories
- Norman D. SchwartzChairman & CEO
- Jonathan P. DiVincenzoPresident & COO
- Roop K. LakkarajuExecutive VP & CFO
- James J. BarryExecutive VP & President of Life Science Group
- Rajat MehtaExecutive Vice President of Global Commercial Operations
- Ruben ArguetaVice President of Investor Relations
- Matthew WernerSenior VP and Chief Compliance & Privacy Officer
- Courtney C. EnloeExecutive VP, General Counsel & Secretary
- Nanditha R. YelamanchiExecutive Vice President of Global Human Resources
- Michael CrowleyExecutive Vice President of Global Commercial Operations
Principais indicadores financeiros
Resultados divulgados pela Bio-Rad Laboratories, em USD.
- Cap. de mercado
- 10,3 bi
- Receita (TTM)
- 2,6 bi
- P/L
- 48.3
- LPA (diluído, TTM)
- 8.0
- Dividend yield
- —
- Margem de lucro
- 8.6%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 2,6 bi | 270,5 mi | 759,9 mi | |
| 2,6 bi | 269 mi | -1,8 bi | |
| 2,7 bi | 337,8 mi | -637,3 mi | |
| 2,8 bi | 482,6 mi | -3,6 bi |